- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有152家主力机构披露2024-06-30报告期持股数据，持仓量总计2.16亿股，占流通A股51.61%
- 波段诊断：
-
技术面诊股
诊断结果：5.3技术面打败了74%的股票
技术面评分前10的股票
近期的平均成本为10.22元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为10.22元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"10.22","date":1736930765,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.01.16","stock":"0.59","trade":"0.36","ind":"0.28"},{"date":"2025.01.15","stock":"-0.10","trade":"-0.76","ind":"-0.43"},{"date":"2025.01.14","stock":"2.42","trade":"2.84","ind":"2.54"},{"date":"2025.01.13","stock":"0.30","trade":"-0.36","ind":"-0.24"},{"date":"2025.01.10","stock":"-2.46","trade":"-3.11","ind":"-1.33"},{"date":"2025.01.09","stock":"-0.20","trade":"-0.50","ind":"-0.58"},{"date":"2025.01.08","stock":"-0.68","trade":"0.09","ind":"0.02"},{"date":"2025.01.07","stock":"-1.44","trade":"-1.79","ind":"0.71"},{"date":"2025.01.06","stock":"2.57","trade":"3.47","ind":"-0.14"},{"date":"2025.01.03","stock":"-2.03","trade":"-1.33","ind":"-1.57"},{"date":"2025.01.02","stock":"-3.18","trade":"-2.14","ind":"-2.66"},{"date":"2024.12.31","stock":"-1.48","trade":"-2.05","ind":"-1.63"},{"date":"2024.12.30","stock":"-1.09","trade":"-1.25","ind":"0.21"},{"date":"2024.12.27","stock":"1.01","trade":"1.17","ind":"0.06"},{"date":"2024.12.26","stock":"0.93","trade":"-0.05","ind":"0.14"},{"date":"2024.12.25","stock":"-0.46","trade":"-1.44","ind":"-0.01"},{"date":"2024.12.24","stock":"0.84","trade":"0.36","ind":"1.26"},{"date":"2024.12.23","stock":"-2.28","trade":"-3.43","ind":"-0.50"},{"date":"2024.12.20","stock":"1.29","trade":"1.14","ind":"-0.06"},{"date":"2024.12.19","stock":"0.00","trade":"-0.04","ind":"-0.36"},{"date":"2024.12.18","stock":"0.00","trade":"-0.07","ind":"0.62"}]
千金药业,上证指数,中药指数
压力支撑
该股压力位为10.19元，支撑位为10.11元。
[{"text":"\u538b\u529b\u4f4d","value":"10.19","date":1736956800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"10.11","date":1736956800,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.0资金面打败了59%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：01月17日 12:16
| 机构今日流向(万元) | -721.44 | 机构5日流向(万元) | -3377.46 |
| 机构10日流向(万元) | -6038.02 | 机构20日流向(万元) | -14162.68 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量增加3622.49万股，其中基金净减仓1家，主力净增仓45家，请投资者中长期谨慎为宜。
截止2024-06-30，共152家主力机构（基金145家，保险公司1家，一般法人2家，社保基金4家），持仓量总计21598.92万股，占流通A股51.61%
其中，基金持仓与2023-12-31相比：
增仓：23家 ，增持 784.42万股
减仓：24家 ，减持 190.40万股
新出现在主力名单中：98家 ，持有3507.07万股
从主力名单中消失：53家 ，原持有1206.31万股
其中，基金持仓与2023-12-31相比：
增仓：23家 ，增持 784.42万股
减仓：24家 ，减持 190.40万股
新出现在主力名单中：98家 ，持有3507.07万股
从主力名单中消失：53家 ，原持有1206.31万股
消息面诊股
诊断结果：5.5消息面打败了60%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 行业追踪|中医药市场（1月6日-1月12日）：综合
2025-01-12 - 行业追踪|中医药市场（12月30日-1月5日）：综
2025-01-05 - 前三季度中成药片剂市场同比略有增长，这类药销售暴涨
2024-12-31 - 行业追踪|中医药市场（12月23日-12月29日）
2024-12-29 - 妇科药行业深度调查研究及市场规模、竞争格局分析
2024-12-27 - 千金药业：千金影城是公司子公司千金文化广场的产业
2024-12-26 - 千金药业：公司卫生用品在抖音、快手、京东、视频号均
2024-12-26 - 千金药业：公司产品获得部分国家销售许可的有妇科千金
2024-12-26 - 千金药业：公司生产经营情况正常，暂无转让股权的计划
2024-12-26 - 湘股并购重组开新局
2024-12-24
消息列表
| 一般消息 | 资产重组 | 公司股权转让 | 2024-09-28 |
| 利好 | 股票增发 | 董事会通过 | 2024-09-07 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-28 |
| 一般消息 | 重大事项 | 关联交易 | 2024-08-27 |
| 一般消息 | 高管变动 | 因工作调整 | 2024-08-23 |
| 一般消息 | 股东大会 | 临时股东大会 | 2024-08-08 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 利好 | 分红转增 | 10派3.5元(含税) | 2024-04-12 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.2行业面打败了80%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.01.16","price":"0.28","value":"0.36"},{"date":"2025.01.15","price":"-0.43","value":"-0.76"},{"date":"2025.01.14","price":"2.54","value":"2.84"},{"date":"2025.01.13","price":"-0.24","value":"-0.36"},{"date":"2025.01.10","price":"-1.33","value":"-3.11"},{"date":"2025.01.09","price":"-0.58","value":"-0.50"},{"date":"2025.01.08","price":"0.02","value":"0.09"},{"date":"2025.01.07","price":"0.71","value":"-1.79"},{"date":"2025.01.06","price":"-0.14","value":"3.47"},{"date":"2025.01.03","price":"-1.57","value":"-1.33"},{"date":"2025.01.02","price":"-2.66","value":"-2.14"},{"date":"2024.12.31","price":"-1.63","value":"-2.05"},{"date":"2024.12.30","price":"0.21","value":"-1.25"},{"date":"2024.12.27","price":"0.06","value":"1.17"},{"date":"2024.12.26","price":"0.14","value":"-0.05"},{"date":"2024.12.25","price":"-0.01","value":"-1.44"},{"date":"2024.12.24","price":"1.26","value":"0.36"},{"date":"2024.12.23","price":"-0.50","value":"-3.43"},{"date":"2024.12.20","price":"-0.06","value":"1.14"},{"date":"2024.12.19","price":"-0.36","value":"-0.04"},{"date":"2024.12.18","price":"0.62","value":"-0.07"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 广誉远 | 1116.78% | 1.75% | 5.9分 |
| 2 | 万邦德 | 173.95% | 0.46% | 5.7分 |
| 3 | 嘉应制药 | 64.22% | -1.70% | 4.4分 |
| 4 | 奇正藏药 | 51.85% | 0.00% | 5.4分 |
| 5 | 众生药业 | 48.69% | -1.98% | 4.7分 |
| 6 | 东阿阿胶 | 4.39% | 0.42% | 4.9分 |
| 8 | 江中药业 | 2.18% | 0.09% | 5.3分 |
| 10 | 健民集团 | 0.69% | 2.65% | 6.2分 |
| 12 | ST百灵 | -1.29% | 3.52% | 4.5分 |
| 14 | 华润三九 | -2.05% | 0.64% | 6.1分 |
| 16 | 以岭药业 | -3.80% | -2.55% | 4.7分 |
| 18 | 特一药业 | -5.17% | -9.15% | 3.1分 |
| 20 | 太龙药业 | -5.42% | -3.44% | 5.6分 |
| 22 | 千金药业 | -5.55% | 0.69% | 5.6分 |
| 24 | 仁和药业 | -5.72% | 0.90% | 4.0分 |
| 26 | 白云山 | -6.42% | 0.07% | 5.3分 |
| 28 | 上海凯宝 | -6.82% | -9.82% | 4.6分 |
| 30 | 恩威医药 | -7.06% | 1.28% | 3.9分 |
| 32 | ST目药 | -7.18% | 2.12% | 5.5分 |
| 34 | 康缘药业 | -8.09% | -0.31% | 5.4分 |
| 36 | 康恩贝 | -8.18% | -1.35% | 5.0分 |
| 38 | 桂林三金 | -9.16% | -1.98% | 4.6分 |
| 40 | 贵州三力 | -9.43% | -2.80% | 5.1分 |
| 42 | 寿仙谷 | -9.51% | 1.11% | 4.4分 |
| 44 | 益盛药业 | -10.18% | 1.38% | 3.9分 |
| 46 | 新光药业 | -10.83% | -0.39% | 3.7分 |
| 48 | 陇神戎发 | -12.30% | -3.30% | 3.7分 |
| 50 | 中恒集团 | -12.96% | 0.86% | 4.6分 |
| 52 | 华森制药 | -13.04% | -2.76% | 4.6分 |
| 54 | 华神科技 | -13.56% | 0.27% | 4.0分 |
| 56 | 葫芦娃 | -14.59% | -10.54% | 4.7分 |
| 58 | 沃华医药 | -16.76% | 1.39% | 4.0分 |
| 60 | 太极集团 | -17.74% | -8.36% | 4.3分 |
| 62 | - | -21.92% | -3.26% | 分 |
| 64 | *ST吉药 | -24.74% | 4.38% | 4.7分 |
| 66 | *ST大药 | -35.95% | -10.50% | 3.4分 |
| 68 | 天士力 | - | 0.00% | 5.4分 |
| 70 | 佛慈制药 | - | 0.52% | 5.0分 |
| 72 | 云南白药 | - | -0.14% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/117 ， 46/117。
[{"date":"2024-09-30","value":"7.00","vol":"3.01"},{"date":"2024-06-30","value":"4.95","vol":"1.51"},{"date":"2024-03-31","value":"1.91","vol":"1.57"},{"date":"2023-12-31","value":"13.91","vol":"1.32"},{"date":"2023-09-30","value":"8.76","vol":"-36.03"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.00 | 4.95 | 1.91 | 13.91 | 8.76 |
| 行业(%) | 3.01 | 1.51 | 1.57 | 1.32 | -36.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"46.05","vol":"52.26"},{"date":"2024-06-30","value":"45.17","vol":"52.53"},{"date":"2024-03-31","value":"45.74","vol":"52.91"},{"date":"2023-12-31","value":"46.12","vol":"53.66"},{"date":"2023-09-30","value":"46.09","vol":"54.60"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
46.05 | 45.17 | 45.74 | 46.12 | 46.09 |
| 行业(%) | 52.26 | 52.53 | 52.91 | 53.66 | 54.60 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 30/117 ， 33/117。
[{"date":"2024-09-30","value":"-2.31","vol":"-4.89"},{"date":"2024-06-30","value":"0.60","vol":"-4.85"},{"date":"2024-03-31","value":"4.22","vol":"-2.72"},{"date":"2023-12-31","value":"-5.66","vol":"3.91"},{"date":"2023-09-30","value":"-4.01","vol":"6.61"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-2.31 | 0.60 | 4.22 | -5.66 | -4.01 |
| 行业(%) | -4.89 | -4.85 | -2.72 | 3.91 | 6.61 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-14.64","vol":"-2.37"},{"date":"2024-06-30","value":"0.87","vol":"-13.99"},{"date":"2024-03-31","value":"5.22","vol":"-11.34"},{"date":"2023-12-31","value":"5.92","vol":"-18.78"},{"date":"2023-09-30","value":"5.20","vol":"9.24"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-14.64 | 0.87 | 5.22 | 5.92 | 5.20 |
| 行业(%) | -2.37 | -13.99 | -11.34 | -18.78 | 9.24 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/117 ， 10/117。
[{"date":"2024-09-30","value":"0.59","vol":"0.36"},{"date":"2024-06-30","value":"0.42","vol":"0.25"},{"date":"2024-03-31","value":"0.21","vol":"0.13"},{"date":"2023-12-31","value":"0.82","vol":"0.53"},{"date":"2023-09-30","value":"0.61","vol":"0.39"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.59 | 0.42 | 0.21 | 0.82 | 0.61 |
| 行业(次) | 0.36 | 0.25 | 0.13 | 0.53 | 0.39 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.85","vol":"1.77"},{"date":"2024-06-30","value":"1.95","vol":"1.21"},{"date":"2024-03-31","value":"1.00","vol":"0.65"},{"date":"2023-12-31","value":"3.61","vol":"2.83"},{"date":"2023-09-30","value":"2.58","vol":"2.04"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.85 | 1.95 | 1.00 | 3.61 | 2.58 |
| 行业(次) | 1.77 | 1.21 | 0.65 | 2.83 | 2.04 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"16.01","vol":"5.27"},{"date":"2024-06-30","value":"10.04","vol":"9.55"},{"date":"2024-03-31","value":"-17.01","vol":"0.64"},{"date":"2023-12-31","value":"36.20","vol":"19.92"},{"date":"2023-09-30","value":"19.64","vol":"7.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 16.01 | 10.04 | -17.01 | 36.20 | 19.64 |
| 行业 | 5.27 | 9.55 | 0.64 | 19.92 | 7.50 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.24","vol":"1.34"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.36","vol":"1.43"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.24 | - | 0.36 | - |
| 行业 | 0.00 | 1.34 | 0.00 | 1.43 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 19/117 ， 44/117。
[{"date":"2024-09-30","value":"2.56","vol":"3.23"},{"date":"2024-06-30","value":"2.40","vol":"2.95"},{"date":"2024-03-31","value":"2.30","vol":"2.98"},{"date":"2023-12-31","value":"2.28","vol":"2.83"},{"date":"2023-09-30","value":"2.25","vol":"2.95"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.56 | 2.40 | 2.30 | 2.28 | 2.25 |
| 行业 | 3.23 | 2.95 | 2.98 | 2.83 | 2.95 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"2.12","vol":"2.43"},{"date":"2024-06-30","value":"1.97","vol":"2.24"},{"date":"2024-03-31","value":"1.91","vol":"2.29"},{"date":"2023-12-31","value":"1.91","vol":"2.15"},{"date":"2023-09-30","value":"1.81","vol":"2.23"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.12 | 1.97 | 1.91 | 1.91 | 1.81 |
| 行业 | 2.43 | 2.24 | 2.29 | 2.15 | 2.23 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 27/117 ， 26/117。
[{"date":"2024-09-30","value":"31.22","vol":"34.45"},{"date":"2024-06-30","value":"33.27","vol":"35.22"},{"date":"2024-03-31","value":"35.09","vol":"34.41"},{"date":"2023-12-31","value":"35.28","vol":"34.63"},{"date":"2023-09-30","value":"35.78","vol":"34.12"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
31.22 | 33.27 | 35.09 | 35.28 | 35.78 |
| 行业(%) | 34.45 | 35.22 | 34.41 | 34.63 | 34.12 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.58","vol":"3.07"},{"date":"2024-06-30","value":"0.63","vol":"1.58"},{"date":"2024-03-31","value":"0.68","vol":"0.95"},{"date":"2023-12-31","value":"0.69","vol":"0.86"},{"date":"2023-09-30","value":"0.71","vol":"0.59"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.58 | 0.63 | 0.68 | 0.69 | 0.71 |
| 行业(%) | 3.07 | 1.58 | 0.95 | 0.86 | 0.59 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"2.97","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"3.02","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"3.04","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.20","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.17","blueLineValue":"0.74","type":"YC"}]